Docetaxel (TXT) is acknowledged as one of the most important chemotherapy agents for
gastric cancer (GC). PI3K/AKT signaling is frequently activated in GC, and its inhibitor …

Co‐encapsulation of abiraterone acetate (AbrA) and docetaxel (Dtx) in polymeric
nanoparticles as novel prototypes for prostate cancer treatment combining hormonal and …

As a well-known anticancer drug, paclitaxel (PTX), a first-line chemotherapeutic agent,
remains unsatisfactory for gastric cancer therapy. It is reported that triptolide (TPL) could …

Objective: To explore the targeting effect of PLGA-NP and iRGD co-administration with
PTXPLGA NP (PTX-PLGA+ iRGD) on colorectal cancer. Methods: Whether PLGA-NP co …

Intestinal cancers are the third most lethal cancers globally, beginning as polyps in the
intestine and spreading with a severe metastatic tendency. Chemotherapeutic drugs used in …

Drug resistance is a major obstacle reducing the efficacy of cancer chemotherapy that
decreases overall survival in breast cancer. P-glycoprotein (P-gp) inhibitors have potential to …

Three types of nanoparticle formulation from biodegradable PLGA-TPGS random copolymer
were developed in this research for oral administration of anticancer drugs, which include …

It is highly tempting to develop high-efficacy targeted nanotherapeutics based on FDA
approved polymers like PLGA. Herein, we describe facile fabrication of robust, hyaluronic …

In the present study, docetaxel (DTX)-loaded poly (lactic-co-glycolic acid)(PLGA) and
polycaprolactone (PCL) nanoparticles were successfully prepared and coated with chitosan …

Paclitaxel (Ptx) is a first-line chemotherapeutic drug for advanced gastric cancer. However,
the poor solubility of Ptx still limits its clinical application. Here, we designed a methoxy poly …